Clinical Trial Update: Uptitration Trial of Flibanserin Versus Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder [Phase 3]

View source ↗

Summary

This is a Phase 3 uptitration trial comparing Flibanserin to placebo in premenopausal women with hypoactive sexual desire disorder. Results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoactive Sexual Desire Disorder

Drugs mentioned

• Flibanserin (Flibanserin)

Snippet

Sponsor: Sprout Pharmaceuticals, Inc | Conditions: Sexual Dysfunctions, Psychological | Phase 3 | Status: COMPLETED | Results posted: 2016-06-27